January 28, 2021By Tiffany Garbutt, PhD, Designer: Gregory Brewer Infographic: Banking on BiologyBiobanking gives scientists access to thousands of biological samples, moving precision medicine one step closer to reality.
Clinical ResearchFebruary 25, 2021By DDN StaffGENUINE progressTG Therapeutics' GENUINE trial shows that ublituximab plus ibrutinib improves survival in patients with chronic lymphocytic leukemia
February 25, 2021By DDN StaffAn alliance for drug developmentUCLA researchers to select candidates for development with Xencor’s modular XmAb platforms
February 24, 2021By Mel J. YeatesBringing down the cost of cancer?NuView’s theranostics approach could make cancer diagnosis and treatment more affordable
February 24, 2021By Kelsey KaustinenA different kind of TROLLAPIS and Moffitt pair up to assess TROLL lncRNAs as predictive biomarkers in cancer
February 19, 2021By Mel J. YeatesIn pursuit of pancreatic cancerStudy finds combination therapy with NAMPT inhibitors and STING agonists can suppress pancreatic tumor growth in mice
DiscoveryFebruary 11, 2021By DDN StaffaTyr begins new tRNA programsaTyr Pharma initiates two new tRNA synthetase discovery programs
February 9, 2021By DDN StaffFDA approves Libtayo for basal cell carcinomaLibtayo receives full approval in locally advanced BCC and accelerated approval in metastatic BCC
Business & Policy NewsFebruary 3, 2021By DDN StaffFDA approves new treatment for NSCLCFDA approves Tepmetko as a once-daily oral MET inhibitor for NSCLC with METex14 skipping alterations
Business & Policy NewsFebruary 2, 2021By Mel J. YeatesA feather in CEVEC’s CAPCARISMA receives full rights for use of CEVEC’s CAP technology in anti-tumor cell therapies
Tools & Techniques NewsJanuary 26, 2021By Kelsey KaustinenA helping hand from HemibodyMorphoSys licenses Hemibody technology from Cherry Biolabs in hopes of improving T cell-based therapeutics